Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$6.46M Sell
178,425
-7,256
-4% -$258K 0.73% 32
2020
Q4
$6.83M Sell
185,681
-11,445
-6% -$420K 0.72% 35
2020
Q3
$6.86M Sell
197,126
-31,945
-14% -$1.12M 0.81% 32
2020
Q2
$9.41M Buy
229,071
+27,756
+14% +$943K 1.07% 20
2020
Q1
$6.23M Sell
201,315
-13,678
-6% -$466K 0.92% 30
2019
Q4
$7.99M Sell
214,993
-3,247
-1% -$116K 0.9% 29
2019
Q3
$7.44M Buy
+218,240
New +$7.94M 0.9% 31

Other funds holding PFE

TCF National Bank's PFE Position: Q1 2021 in Review

TCF National Bank reduced its Pfizer (PFE) stake by 3.9% in Q1 2021, selling an estimated $258K and leaving 178,425 shares worth $6.46M. The position accounts for 0.73% of the portfolio, ranked #32.

TCF National Bank first reported a position in PFE in Q3 2019 and has held it in 7 quarters since. The position peaked at $9.41M in Q2 2020. 2,675 funds tracked by Wall St. Rank hold PFE as of Q1 2021.

  • TCF National Bank held 178,425 shares of Pfizer worth $6.46M as of Q1 2021.
  • TCF National Bank sold 7,256 Pfizer shares in Q1 2021, an estimated $258K.
  • Pfizer made up 0.73% of TCF National Bank's portfolio in Q1 2021, its #32 holding.
  • TCF National Bank first reported a position in Pfizer in Q3 2019 and has held it in 7 quarters since.
  • TCF National Bank's Pfizer position peaked at $9.41M in Q2 2020.
  • 2,675 funds tracked by Wall St. Rank held Pfizer as of Q1 2021.

Based on TCF National Bank's 13F filing for Q1 2021, filed 30 Apr 2021.